News Formal

Stocks are little changed Tuesday as traders assess fresh earnings and new data: Live updates

  • 📰 CNBC
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 72%

Norge Nyheter Nyheter

Norge Siste Nytt,Norge Overskrifter

Stocks were flat Tuesday as the market rally took another breather, with investors looking ahead to key data slated for release later this week.

Eli Lilly shares have been riding the excitement over anti-obesity drugs for quite a while, but not today. Shares were down slightly as investors rallied around Viking Therapeutics , a clinical stage biopharmaceutical company that is developing an oral drug that would compete with Lilly's Zepbound. Viking's therapy, VK2735, showed promising results in a phase 2 trial . Patients enrolled in the study tolerated the drug very well, with very few stopping treatment.

mountain Viking stock year to date. Viking shares were up more than 90% in recent trading. Even ahead of Tuesday's news, the stock has soared so far this year. Although Viking's results are promising, analysts believe the market is so vast for these drugs that there is an opportunity for additional players. Also both Novo Nordisk and Lilly, the market leaders, also have next-generation drugs in their pipeline.

 

Takk for kommentaren din. Kommentaren din vil bli publisert etter gjennomgang.
Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

 /  🏆 12. in NO

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

European markets lower as sentiment struggles; Barclays rises on earningsEuropean stocks were lower Tuesday as sentiment struggles to pick up in global markets.
Kilde: CNBC - 🏆 12. / 72 Les mer »